# Kyntra Bio, Inc.: Form 8-K, filed Oct 3, 2024

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2024-10-03
- Accepted by EDGAR: Oct 3, 2024, 20:05 ET
- Period: 2024-09-27
- Accession: 0000950170-24-112331
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000095017024112331/fgen-20240927.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000095017024112331/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000095017024112331/fgen-20240927.htm

Filed Oct 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-112331. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.